ANNE THORNE-PICARD: Open Payments
NPI 1326392937 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 17 payments from 16 companies in 2025. Trend: 2023 $1,739 · 2024 $1,433 · 2025 $2,190
Food & beverage: $2,190
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $295 |
| Insulet Corporation | 1 | $169 |
| Actelion Pharmaceuticals US, Inc. | 1 | $148 |
| CVRx, Inc. | 1 | $138 |
| Gilead Sciences, Inc. | 1 | $132 |
| Dexcom, Inc. | 1 | $130 |
| Boston Scientific Corporation | 1 | $129 |
| Corcept Therapeutics | 1 | $127 |
| GENZYME CORPORATION | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, OMNIPOD, UPTRAVI, Barostim Neo System, DEXCOM G7 GSS (161), WATCHMAN FLX, Korlym, CEREZYME.
Industry payments across FL — which companies pay providers there.
